15th July 2019
Effective 1 January 2018
EIT Health UK-Ireland partners Innovation Agency (AHSN for the North West Coast) and Oxford AHSN have successfully upgraded their status to core partner, effective 1 January 2018. Both the Innovation Agency and Oxford AHSN share EIT Health challenges of promoting healthy living, supporting active ageing and improving healthcare, through innovations that empower patients.
In particular, the Innovation Agency is a catalysts for the spread of innovation at pace and scale – improving health, generating economic growth and helping facilitate change across whole health and social care economies. The Innovation Agency connects regional networks of NHS and academic organisations, local authorities, the third sector and industry. It creates the right environment for relevant industries to work with the health and social care system.
The Oxford Academic Health Science Network (Oxford AHSN) works with a large and growing list of partners in the NHS, universities and industry within and beyond their region. Their strategy is designed to achieve four objectives with NHS England:
- Focus on the needs of patients and local populations;
- Speed up adoption of innovation into practice to improve clinical outcomes and patient experience;
- Build a culture of partnership and collaboration; and
- Create wealth.
You can read more about the Innovation Agency and Oxford AHSN’s assets in the relative cards in the UK-Ireland CLC’s Partnership Portfolio.
The recent upgrade of the Innovation Agency and Oxford AHSN’s status to core partners is wonderful news for the UK-Ireland community. The UK-Ireland CLC looks forward to supporting them with EIT Health projects and activities going forward.
For the partnership portfolio innovation agency click here
For the partnership portfolio oxford click here
For more information on Innovation Agency (AHSN for the North West Coast) click here
For more information on Oxford AHSN click here
Four exciting companies receive expert mentoring
EIT Health helps promising firms commercialise
Supported start-up launches AI platform with Roche
Helping cancer patients with AI
EIT Health supported start-up Unhindr awarded £500,000
Unhindr has won funding to scale AI prosthetic device